Literature DB >> 17381430

Characterization of the interaction between anthrax toxin and its cellular receptors.

Shihui Liu1, Howard J Leung, Stephen H Leppla.   

Abstract

Mutations in capillary morphogenesis gene 2 (CMG2), one of the two closely related proteins that act as anthrax toxin receptors, cause two rare human autosomal recessive conditions, juvenile hyaline fibromatosis (JHF) and infantile systemic hyalinosis (ISH). Here we demonstrate that CMG2 proteins with certain JHF- and ISH-associated single amino acid substitutions in their von Willebrand factor A domain or transmembrane region do not function as anthrax toxin receptors. However, an ISH-associated CMG2 variant having a truncated cytosolic domain does still function as an anthrax receptor, and in fact makes cells hyper-sensitive to toxin, distinguishing the roles of CMG2 in physiology and anthrax pathology. Site-specific mutagenesis was used to characterize the role that domain 2 of the anthrax toxin protective antigen (PA) plays in interaction with CMG2, focusing on the interaction between the PA 2beta(3)-2beta(4) loop and a pocket (Glu-122 pocket) adjacent to the metal ion-dependent adhesion site in CMG2. Substitutions that disrupted the salt bridge between PA Arg-344 and CMG2 Glu-122 decreased the affinity of PA to CMG2 three- to fourfold. Furthermore, mutation of CMG2 Tyr-119 (within the Glu-122 pocket) to His lowered the pH threshold for PA prepore-to-pore conversion in the endocytic pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17381430      PMCID: PMC2459336          DOI: 10.1111/j.1462-5822.2006.00845.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  33 in total

1.  Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.

Authors:  Shihui Liu; Stephen H Leppla
Journal:  J Biol Chem       Date:  2002-12-04       Impact factor: 5.157

2.  Retroviral insertional mutagenesis identifies a small protein required for synthesis of diphthamide, the target of bacterial ADP-ribosylating toxins.

Authors:  Shihui Liu; Stephen H Leppla
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

3.  TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).

Authors:  Akash Nanda; Eleanor B Carson-Walter; Steven Seaman; Thomas D Barber; Jason Stampfl; Sujay Singh; Bert Vogelstein; Kenneth W Kinzler; Brad St Croix
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

4.  Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.

Authors:  Heather M Scobie; G Jonah A Rainey; Kenneth A Bradley; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

5.  Identification of the cellular receptor for anthrax toxin.

Authors:  K A Bradley; J Mogridge; M Mourez; R J Collier; J A Young
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

6.  Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.

Authors:  Oonagh Dowling; Analisa Difeo; Maria C Ramirez; Turgut Tukel; Goutham Narla; Luisa Bonafe; Hulya Kayserili; Memnune Yuksel-Apak; Amy S Paller; Karen Norton; Ahmad S Teebi; Valerie Grum-Tokars; Gail S Martin; George E Davis; Marc J Glucksman; John A Martignetti
Journal:  Am J Hum Genet       Date:  2003-09-12       Impact factor: 11.025

7.  Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis.

Authors:  Sandra Hanks; Sarah Adams; Jenny Douglas; Laura Arbour; David J Atherton; Sevim Balci; Harald Bode; Mary E Campbell; Murray Feingold; Gökhan Keser; Wim Kleijer; Grazia Mancini; John A McGrath; Francesco Muntoni; Arti Nanda; M Dawn Teare; Matthew Warman; F Michael Pope; Andrea Superti-Furga; P Andrew Futreal; Nazneen Rahman
Journal:  Am J Hum Genet       Date:  2003-08-21       Impact factor: 11.025

8.  Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody.

Authors:  M J Rosovitz; Peter Schuck; Mini Varughese; Arun P Chopra; Varsha Mehra; Yogendra Singh; Lisa M McGinnis; Stephen H Leppla
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

Review 9.  Anthrax toxin: structures, functions and tumour targeting.

Authors:  Shihui Liu; Rebecca L Schubert; Thomas H Bugge; Stephen H Leppla
Journal:  Expert Opin Biol Ther       Date:  2003-08       Impact factor: 4.388

10.  Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.

Authors:  S E Bell; A Mavila; R Salazar; K J Bayless; S Kanagala; S A Maxwell; G E Davis
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  35 in total

Review 1.  Occurrence, recognition, and reversion of spontaneous, sporulation-deficient Bacillus anthracis mutants that arise during laboratory culture.

Authors:  Inka Sastalla; Stephen H Leppla
Journal:  Microbes Infect       Date:  2011-11-28       Impact factor: 2.700

2.  Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.

Authors:  Shihui Liu; Sharmina Miller-Randolph; Devorah Crown; Mahtab Moayeri; Inka Sastalla; Shu Okugawa; Stephen H Leppla
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

3.  Key tissue targets responsible for anthrax-toxin-induced lethality.

Authors:  Shihui Liu; Yi Zhang; Mahtab Moayeri; Jie Liu; Devorah Crown; Rasem J Fattah; Alexander N Wein; Zu-Xi Yu; Toren Finkel; Stephen H Leppla
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

4.  Human genetic variation altering anthrax toxin sensitivity.

Authors:  Mikhail Martchenko; Sophie I Candille; Hua Tang; Stanley N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

5.  Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin.

Authors:  Shihui Liu; Thomas H Bugge; Arthur E Frankel; Stephen H Leppla
Journal:  Methods Mol Biol       Date:  2009

6.  The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen.

Authors:  Mandy Y Go; Edith M C Chow; Jeremy Mogridge
Journal:  Infect Immun       Date:  2008-10-20       Impact factor: 3.441

7.  Evidence that histidine protonation of receptor-bound anthrax protective antigen is a trigger for pore formation.

Authors:  D Shyamali Wimalasena; Blythe E Janowiak; Scott Lovell; Masaru Miyagi; Jianjun Sun; Haiying Zhou; Jan Hajduch; Chaya Pooput; Kenneth L Kirk; Kevin P Battaile; James G Bann
Journal:  Biochemistry       Date:  2010-08-24       Impact factor: 3.162

8.  Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.

Authors:  Maheshinie Rajapaksha; Jack F Eichler; Jan Hajduch; David E Anderson; Kenneth L Kirk; James G Bann
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

9.  The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.

Authors:  Sheng Fu; Xiaohang Tong; Chenguang Cai; Ying Zhao; Yang Wu; Yuanyuan Li; Junjie Xu; Xuejun C Zhang; Long Xu; Wei Chen; Zihe Rao
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

10.  Quantitative high-throughput screening identifies inhibitors of anthrax-induced cell death.

Authors:  Ping Jun Zhu; John P Hobson; Noel Southall; Cunping Qiu; Craig J Thomas; Jiamo Lu; James Inglese; Wei Zheng; Stephen H Leppla; Thomas H Bugge; Christopher P Austin; Shihui Liu
Journal:  Bioorg Med Chem       Date:  2009-05-29       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.